Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study

References

• Osterberg L, Blaschke T. Adherence to medication. N Eng J Med. 2005;353:487–497. doi:10.1056/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. doi:10.1136/bmj.38875.675486.55
   PubMed Web of Science ®Google Scholar
• DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–209. doi:10.1097/01.mlr.0000114908.90348.f9
   PubMed Web of Science ®Google Scholar
• Vermeire E, Hearnshaw H, van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331–342. doi:10.1046/j.1365-2710.2001.00363.x
   PubMed Web of Science ®Google Scholar
• Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36(8):1138–1161. doi:10.1097/00005650-199808000-00004
   PubMed Web of Science ®Google Scholar
• Malek N, Heath CA, Greene J. A review of medication adherence in people with epilepsy. Acta Neurol Scand. 2017;135(5):507–515. doi:10.1111/ane.12703
   PubMed Web of Science ®Google Scholar
• Specht U. Medikamenten-Compliance bei Epilepsie [Compliance with antiepileptic drugs]. Nervenarzt. 2008;79(6):662–668. doi:10.1007/s00115-008-2408-3
   Web of Science ®Google Scholar
• Petermann F, Tampe T. Compliance bei chronisch kranken Kindern und Jugendlichen [Compliance in children and adolescents with chronic illness]. Kindheit und Entwicklung. 2002;11(1):3–13. doi:10.1026//0942-5403.11.1.3
   Google Scholar
• Jarvie S. Epilepsy knowledge, beliefs and education. In: Pfäfflin M, Fraser RT, Thorbecke R, Specht U, Wolf P, editors. Comprehensive Care for People with Epilepsy. Eastleigh: John Libbey & Company Ltd; 2001:23–34.
   Google Scholar
• Long L, Reeves AL, Moore JL, Roach J, Pickering CT. An assessment of epilepsy patients’ knowledge of their disorder. Epilepsia. 2000;41(6):727–731. doi:10.1111/j.1528-1157.2000.tb00235.x
   Web of Science ®Google Scholar
• Nerius M, Ziegler U, Doblhammer G, Fink A. Trends in der Prävalenz von Demenz und Parkinson – eine Analyse auf Basis aller gesetzlich versicherten Personen im Alter 65+ in Deutschland zwischen 2009 und 2012 [Trends in the Prevalence of Dementia and Parkinson’s Disease: an Analysis Based on Health Claims Data from all German Statutory Health Insurance Funds for Persons aged 65+ in Germany 2009–2012]. Gesundheitswesen. 2020;82(10):761–769. doi:10.1055/a-0829-6494
   Web of Science ®Google Scholar
• Davis KL, Edin HM, Allen JK. Prevalence and cost of medication nonadherence in Parkinson’s disease: evidence from administrative claims data. Mov Disord. 2010;25(4):474–480. doi:10.1002/mds.22999
   PubMed Web of Science ®Google Scholar
• Leoni O, Martignoni E, Cosentino M, et al. Drug prescribing patterns in Parkinson’s disease: a pharmacoepidemiological survey in a cohort of ambulatory patients. Pharmacoepidemiol Drug Saf. 2002;11(2):149–157. doi:10.1002/pds.682
   PubMed Web of Science ®Google Scholar
• Grosset KA, Bone I, Grosset DG. Suboptimal medication adherence in Parkinson’s disease. Mov Disord. 2005;20(11):1502–1507. doi:10.1002/mds.20602
   PubMed Web of Science ®Google Scholar
• Á S, Arbelo JM, Del Val JL. Treatment of Parkinson disease, time and dosage: “does simple dosage facilitate compliance and therapeutic goals?”. Neurologist. 2011;17:S43–46. doi:10.1097/NRL.0b013e31823968d3
   Google Scholar
• Wei Y-J, Palumbo FB, Simoni-Wastila L, et al. Antiparkinson drug use and adherence in medicare part d beneficiaries with Parkinson’s disease. Clin Ther. 2013;35(10):1513–1525. doi:10.1016/j.clinthera.2013.09.001
   Web of Science ®Google Scholar
• Malek N, Grosset DG. Medication adherence in patients with Parkinson’s disease. CNS Drugs. 2015;29(1):47–53. doi:10.1007/s40263-014-0220-0
   PubMed Web of Science ®Google Scholar
• Daley DJ, Myint PK, Gray RJ, Deane KHO. Systematic review on factors associated with medication non-adherence in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18(10):1053–1061. doi:10.1016/j.parkreldis.2012.09.004
   PubMed Web of Science ®Google Scholar
• Nguyen T-M-U, La Caze A, Cottrell N. What are validated self‐report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol. 2014;77(3):427–445. doi:10.1111/bcp.12194
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel‐Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x
   PubMed Web of Science ®Google Scholar
• Culig J, From LM. Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Coll Antropol. 2014;38(1):55–62.
   PubMedGoogle Scholar
• Vrijens B, De Geest S, Hughes DA. Geest S de, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clinl Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• Sabaté E. Adherence to long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
   Google Scholar
• Tosin MHS, Stebbins GT, Goetz CG, Santana RF, Leite MAA, Oliveira BGR. Measuring medication adherence in Parkinson’s disease: a systematic review of contributing components in rating scales. Mov Disord Clin Pract. 2020;7(6):607–615. doi:10.1002/mdc3.13006
   PubMed Web of Science ®Google Scholar
• Kristofferzon M-L, Engström M, Nilsson A. Coping mediates the relationship between sense of coherence and mental quality of life in patients with chronic illness: a cross-sectional study. Qual Life Res. 2018;27(7):1855–1863. doi:10.1007/s11136-018-1845-0
   PubMed Web of Science ®Google Scholar
• Martz E, Livneh H, eds. Coping with Chronic Illness and Disability. New York: Springer; 2007.
   Google Scholar
• Mikula P, Nagyova I, Krokavcova M, et al. Coping and its importance for quality of life in patients with multiple sclerosis. Disabil Rehabil. 2014;36(9):732–736. doi:10.3109/09638288.2013.808274
   PubMed Web of Science ®Google Scholar
• Backer JH. Stressors, social support, coping, and health dysfunction in individuals with Parkinson’s disease. J Gerontol Nurs. 2000;26(11):6–9. doi:10.3928/0098-9134-20001101-05
   Google Scholar
• Frazier LD. Coping with disease-related stressors in Parkinson’s disease. Gerontologist. 2000;40(1):53–63.
   PubMed Web of Science ®Google Scholar
• Schreurs KMG, De Ridder DTD, Bensing JM. A one year study of coping, social support and quality of life in Parkinson’s disease. Psychol Health. 2000;15(1):109–121. doi:10.1080/08870440008400292
   Web of Science ®Google Scholar
• Montel S, Bonnet A-M BC. Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson’s disease. J Geriatr Psychiatry Neurol. 2009;22(2):95–102. doi:10.1177/0891988708328219
   PubMed Web of Science ®Google Scholar
• Bucks RS, Cruise KE, Skinner TC, Loftus AM, Barker RA, Thomas MG. Coping processes and health‐related quality of life in Parkinson’s disease. Int J Geriatr Psychiatry. 2011;26(3):247–255. doi:10.1002/gps.2520
   Web of Science ®Google Scholar
• Franke GH, Nentzl J, Jagla-Franke M. SAMS - Stendal Adherence with Medication Score.: deutsches Manual. Psychometrikon. 2020. Available from: https://www.psychometrikon.de/inhalt/suchen/test.php?id=ff32ee9ea015021c3fb047e505e2bc45. Accessed April 17, 2021.
   Google Scholar
• Franke GH, Nentzl J, Küch D, Die J-FM. Erfassung der Medikamenten-Adhärenz bei Schmerzpatientinnen und -patienten [Assessment of adherence to medication in pain patients]. Klinische Verhaltensmedizin und Rehabilitation. 2020;33(2):27–39.
   Google Scholar
• Prell T, Grosskreutz J, Mendorf S, Franke GH, Witte OW, Kunze A. Clusters of non-adherence to medication in neurological patients. Res Social Adm Pharm. 2019;15(12):1419–1424. doi:10.1016/j.sapharm.2019.01.001
   PubMed Web of Science ®Google Scholar
• Franke GH, Jagla M ECQ – essen Coping Questionnaire Test Manual – English version. Psychometrikon. Available from: http://psychometrikon.de/inhalt/suchen/test.php?id=b2c6285c00324df0956e23257eb0e176. Accessed April 17, 2021.
   Google Scholar
• Coca V, Nink K, Schröder H. Arzneimittelverordnungen nach Alter und Geschlecht. In: Schwabe U, Paffrath D, editors. Arzneiverordnungs-Report 2007. Berlin: Springer; 2008:919–932.
   Google Scholar
• Kruse A, Gaber E, Heuft G, Oster P, Re S, Schulz-Nieswandt F. Themenheft 10” Gesundheit im Alter”. Berlin: RKI; 2002.
   Google Scholar
• Marcum ZA, Gellad WF. Medication adherence to multidrug regimens. Clin Geriatr Med. 2012;28(2):287–300. doi:10.1016/j.cger.2012.01.008
   PubMed Web of Science ®Google Scholar
• Jüngst C, Gräber S, Simons S, Wedemeyer H, Lammert F. Medication adherence among patients with chronic diseases: a survey-based study in pharmacies. QJM. 2019;112(7):505–512. doi:10.1093/qjmed/hcz058
   PubMed Web of Science ®Google Scholar
• Jäger S, Franke GH, Reimer J, et al. Der Zusammenhang zwischen Medikamenten-Compliance und gesundheitsbezogener Lebensqualität bei Nierentransplantierten [Relationship between adherence to medication and health related quality of life in kidney transplanted patients]. In: Klinische Psychologie AK, im BDP, editor. Psychische Störungen in der somatischen Rehabilitation. Berlin: dpv;2009:79–93.
   Google Scholar
• Manteuffel M, Williams S, Chen W, Verbrugge RR, Pittman DG, Steinkellner A. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Womens Health (Larchmt). 2014;23(2):112–119. doi:10.1089/jwh.2012.3972
   PubMed Web of Science ®Google Scholar
• El-Saifi N, Moyle W, Jones C, Tuffaha H. Medication adherence in older patients with dementia: a systematic literature review. J Pharm Pract. 2018;31(3):322–334. doi:10.1177/0897190017710524
   Web of Science ®Google Scholar
• Kobau R, DiIorio C. Epilepsy self-management: a comparison of self-efficacy and outcome expectancy for medication adherence and lifestyle behaviors among people with epilepsy. Epilepsy Behav. 2003;4(3):217–225. doi:10.1016/S1525-5050(03)00057-X
   PubMed Web of Science ®Google Scholar
• Fraser C, Morgante L, Hadjimichael O, Vollmer T. A prospective study of adherence to glatiramer acetate in individuals with multiple sclerosis. J Neurosci Nurs. 2004;36(3):120–130. doi:10.1097/01376517-200406000-00002
   Google Scholar
• Kyngäs H. Compliance with health regimens of adolescents with epilepsy. Seizure. 2000;9(8):598–604. doi:10.1053/seiz.2000.0470
   PubMed Web of Science ®Google Scholar
• Bajaj B, Pande N. Mediating role of resilience in the impact of mindfulness on life satisfaction and affect as indices of subjective well-being. Pers Individ Dif. 2016;93:63–67. doi:10.1016/j.paid.2015.09.005
   Web of Science ®Google Scholar
• Liu X, Xu W, Wang Y, et al. Can inner peace be improved by mindfulness training: a randomized controlled trial. Stress Health. 2015;31(3):245–254. doi:10.1002/smi.2551
   PubMed Web of Science ®Google Scholar
• Lima S, Gago M, Garrett C, Pereira MG. Medication adherence in Alzheimer’s disease: the mediator role of mindfulness. Arch Gerontol Geriatr. 2016;67:92–97. doi:10.1016/j.archger.2016.06.021
   Web of Science ®Google Scholar
• Salmoirago-Blotcher E, Carey MP. Can mindfulness training improve medication adherence? Integrative review of the current evidence and proposed conceptual model. Explore (NY). 2018;14(1):59–65. doi:10.1016/j.explore.2017.09.010
   Google Scholar
• Dilorio C, Henry M. Self-management in persons with epilepsy. J Neurosci Nurs. 1995;27(6):338–343. doi:10.1097/01376517-199512000-00004
   Google Scholar
• Nieuwlaat R, Wilczynski N, Navarro T. et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev;2014. 11. doi:10.1002/14651858.CD000011.pub4
   Web of Science ®Google Scholar
• Dunbar J. Predictors of patient adherence: patient characteristics. In: Shumaker SA, Schron EB, Ockene JK, Parker CT, Probstfield JL, Wolle JM, editors. The Handbook of Health Behavior Change. New York: Springer; 1990:348–360.
   Google Scholar
• Lamarche L, Tejpal A, Mangin D. Self-efficacy for medication management: a systematic review of instruments. Patient Prefer Adherence. 2018;12:1279–1287. doi:10.2147/PPA.S165749
   Web of Science ®Google Scholar
• Náfrádi L, Nakamoto K, Schulz PJ. Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PLoS One. 2017;12(10):e0186458. doi:10.1371/journal.pone.0186458
   PubMed Web of Science ®Google Scholar
• Pagès-Puigdemont N, Mangues MA, Masip M, et al. Patients’ perspective of medication adherence in chronic conditions: a qualitative study. Adv Ther. 2016;33(10):1740–1754. doi:10.1007/s12325-016-0394-6
   PubMed Web of Science ®Google Scholar
• Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev Med. 2017;99:269–276. doi:10.1016/j.ypmed.2017.03.008
   PubMed Web of Science ®Google Scholar
• Eaker S, Bergström R, Bergström A, Adami HO, Nyren O. Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol. 1998;147(1):74–82. doi:10.1093/oxfordjournals.aje.a009370
   PubMed Web of Science ®Google Scholar
• Hardie JA, Bakke PS, Mørkve O. Non-response bias in a postal questionnaire survey on respiratory health in the old and very old. Scand J Public Health. 2003;31(6):411–417. doi:10.1177/140349480303100603
   PubMed Web of Science ®Google Scholar
• Trigg R, Jones RW, Skevington SM. Can people with mild to moderate dementia provide reliable answers about their quality of life? Age Ageing. 2007;36(6):663–669. doi:10.1093/ageing/afm077
   PubMed Web of Science ®Google Scholar